Department of General Surgery, Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
Department of Gastrointestinal Cancer Center, Chongqing University Cancer Hospital, Chongqing, China.
Syst Rev. 2024 Jan 6;13(1):19. doi: 10.1186/s13643-023-02445-5.
Distal gastrectomy (DG) is a commonly used surgical procedure for gastric cancer (GC), with three reconstruction methods available: Billroth I, Billroth II, and Roux-en-Y. In 2018, our team published a systematic review to provide guidance for clinical practice on the optimal reconstruction method after DG for GC. However, since then, new evidence from several randomized controlled trials (RCTs) has emerged, prompting us to conduct an updated systematic review and network meta-analysis to provide the latest comparative estimates of the efficacy and safety of the three reconstruction methods after DG for GC.
This systematic review and network meta-analysis update followed the PRISMA-P guidelines and will include a search of PubMed, Embase, and the Cochrane Library for RCTs comparing the outcomes of Billroth I, Billroth II, or Roux-en-Y reconstruction after DG for patients with GC. Two independent reviewers will screen the titles and abstracts based on predefined eligibility criteria, and two reviewers will assess the full texts of relevant studies. The Bayesian network meta-analysis will evaluate various outcomes, including quality of life after surgery, anastomotic leakage within 30 days after surgery, operation time, intraoperative blood loss, major postoperative complications within 30 days after surgery, incidence and severity of bile reflux, and loss of body weight from baseline.
The review does not require ethical approval. The findings of the review will be disseminated through publication in an academic journal, presentations at conferences, and various media outlets.
INPLASY2021100060.
远端胃切除术(DG)是治疗胃癌(GC)的常用手术方法,有三种重建方法:毕罗氏 I 式、毕罗氏 II 式和 Roux-en-Y。2018 年,我们团队发表了一篇系统评价,为 DG 治疗 GC 后的最佳重建方法提供了临床实践指南。然而,此后,几项随机对照试验(RCT)的新证据出现,促使我们进行了更新的系统评价和网络荟萃分析,以提供 DG 治疗 GC 后三种重建方法的疗效和安全性的最新比较估计。
本系统评价和网络荟萃分析更新遵循 PRISMA-P 指南,并将包括对比较 DG 治疗 GC 患者后毕罗氏 I 式、毕罗氏 II 式或 Roux-en-Y 重建结果的 RCT 的 PubMed、Embase 和 Cochrane 图书馆进行检索。两名独立审查员将根据预先确定的纳入标准筛选标题和摘要,两名审查员将评估相关研究的全文。贝叶斯网络荟萃分析将评估各种结局,包括手术后生活质量、手术后 30 天内吻合口漏、手术时间、术中出血量、手术后 30 天内主要术后并发症、胆汁反流发生率和严重程度,以及从基线开始的体重损失。
本综述不需要伦理批准。综述结果将通过在学术期刊上发表、会议上展示以及各种媒体渠道传播。
INPLASY 注册号:INPLASY2021100060。